These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17956100)

  • 1. A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity.
    Palacios DS; Anderson TM; Burke MD
    J Am Chem Soc; 2007 Nov; 129(45):13804-5. PubMed ID: 17956100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B.
    Paquet V; Volmer AA; Carreira EM
    Chemistry; 2008; 14(8):2465-81. PubMed ID: 18196508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine.
    Paquet V; Carreira EM
    Org Lett; 2006 Apr; 8(9):1807-9. PubMed ID: 16623556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically active amphotericin B-calix[4]arene conjugates.
    Paquet V; Zumbuehl A; Carreira EM
    Bioconjug Chem; 2006; 17(6):1460-3. PubMed ID: 17105224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New N-alkyl derivatives of amphotericin B. Synthesis and biological properties.
    Czerwiński A; König WA; Zieniawa T; Sowiński P; Sinnwell V; Milewski S; Borowski E
    J Antibiot (Tokyo); 1991 Sep; 44(9):979-84. PubMed ID: 1938621
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents.
    Vandekerckhove S; Tran HG; Desmet T; D'hooghe M
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4641-3. PubMed ID: 23838261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities.
    Palacios DS; Dailey I; Siebert DM; Wilcock BC; Burke MD
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6733-8. PubMed ID: 21368185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm.
    Randhawa MA; Gondal MA; Al-Zahrani AH; Rashid SG; Ali A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(2):119-24. PubMed ID: 25560257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation by spray drying of amphotericin B-phospholipid composite particles and their anticellular activity.
    Kim JC; Kim JD
    Drug Deliv; 2001; 8(3):143-7. PubMed ID: 11570594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological studies of 35-deoxy amphotericin B methyl ester.
    Szpilman AM; Manthorpe JM; Carreira EM
    Angew Chem Int Ed Engl; 2008; 47(23):4339-42. PubMed ID: 18442156
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro evaluation of antifungal and cytotoxic activities as also the therapeutic safety of the oxidized form of amphotericin B.
    Klimek K; Strubińska J; Czernel G; Ginalska G; Gagoś M
    Chem Biol Interact; 2016 Aug; 256():47-54. PubMed ID: 27350166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyketide glycosides phialotides A to H, new potentiators of amphotericin B activity, produced by Pseudophialophora sp. BF-0158.
    Yagi A; Uchida R; Kobayashi K; Tomoda H
    J Antibiot (Tokyo); 2020 Apr; 73(4):211-223. PubMed ID: 31974520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
    Kubo I; Muroi H; Himejima M
    J Nat Prod; 1993 Feb; 56(2):220-6. PubMed ID: 8463795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 15. N-methyl-N-D-fructopyranosylamphotericin B methyl ester, new amphotericin B derivative of low toxicity.
    Grzybowska J; Sowiński P; Gumieniak J; Zieniawa T; Borowski E
    J Antibiot (Tokyo); 1997 Aug; 50(8):709-11. PubMed ID: 9315089
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and biological evaluation of amphotericin B derivatives.
    Volmer AA; Szpilman AM; Carreira EM
    Nat Prod Rep; 2010 Sep; 27(9):1329-49. PubMed ID: 20556271
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in some Candida albicans virulence factors due to amphotericin-B post-antifungal effect.
    Ozkutuk A; Dogan Y; Kirdar S; Ozkutuk N
    J Chemother; 2007 Feb; 19(1):101-3. PubMed ID: 17309860
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and investigation of tryptophan-amphotericin B conjugates.
    Zumbuehl A; Stano P; Sohrmann M; Dietiker R; Peter M; Carreira EM
    Chembiochem; 2009 Jul; 10(10):1617-20. PubMed ID: 19533712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
    Medoff G; Kobayashi GS; Kwan CN; Schlessinger D; Venkov P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of NH
    Zhang J; Ma J; Dong Y; Zhao W; Feng J
    J Antibiot (Tokyo); 2019 Apr; 72(4):210-217. PubMed ID: 30635615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.